290 Clinical Study of RLS-1496 Topical Cream: Targeting Cellular Senescence in Patients with Mild to Moderate Plaque Psoriasis, Atopic Dermatitis, and Aged Skin
Journal of Investigative Dermatology · 2025-11 · 145 (11) · e77
DOI: 10.1016/j.jid.2025.09.294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Mary Spellman und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Spellman, M., Beddingfield, F., Quarta, M., & Moreno, O. (2025). 290 Clinical Study of RLS-1496 Topical Cream: Targeting Cellular Senescence in Patients with Mild to Moderate Plaque Psoriasis, Atopic Dermatitis, and Aged Skin. Journal of Investigative Dermatology, 145(11), e77. https://doi.org/10.1016/j.jid.2025.09.294
Vancouver
Spellman M, Beddingfield F, Quarta M, Moreno O. 290 Clinical Study of RLS-1496 Topical Cream: Targeting Cellular Senescence in Patients with Mild to Moderate Plaque Psoriasis, Atopic Dermatitis, and Aged Skin. Journal of Investigative Dermatology. 2025;145(11):e77. doi:10.1016/j.jid.2025.09.294
BibTeX
@article{Spellman2025,
author = {Spellman, Mary and Beddingfield, Frederick and Quarta, Marco and Moreno, Ofir},
title = {290 Clinical Study of RLS-1496 Topical Cream: Targeting Cellular Senescence in Patients with Mild to Moderate Plaque Psoriasis, Atopic Dermatitis, and Aged Skin},
journal = {Journal of Investigative Dermatology},
year = {2025},
volume = {145},
number = {11},
pages = {e77},
doi = {10.1016/j.jid.2025.09.294}
}
EUVIMED